• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

    4/11/24 8:03:24 AM ET
    $FAST
    $GRFS
    $KMX
    $LOVE
    RETAIL: Building Materials
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $FAST alert in real time by email

    U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday.

    Shares of CarMax, Inc. (NYSE:KMX) fell sharply in today’s pre-market trading after the company reported lower-than-expected fourth-quarter earnings.

    • CarMax posted quarterly earnings of 32 cents per share, missing market estimates of 49 cents per share. The company’s quarterly sales came in at $5.63 billion versus expectations of $5.79 billion, according to data from Benzinga Pro.
    • CarMax shares dipped 9.1% to $72.06 in pre-market trading.
    • Here are some big stocks recording losses in today’s pre-market trading session.
    • The Lovesac Company (NASDAQ:LOVE) shares fell 13% to $20.30 in pre-market trading after the company reported worse-than-expected fourth-quarter results and issued first-quarter guidance.
    • Nyxoah S.A. (NASDAQ:NYXH) shares dipped 12.4% to $9.30 in pre-market trading.
    • AVITA Medical, Inc. (NASDAQ:RCEL) shares fell 11.6% to $12.76 in pre-market trading after the company announced an update to its expected commercial revenue for the first quarter of 2024. BTIG downgraded the stock from Buy to Neutral.
    • DigiAsia Corp. (NASDAQ:FAAS) shares fell 7.1% to $8.11 in pre-market trading after jumping around 19% on Wednesday.
    • Nanobiotix S.A. (NASDAQ:NBTX) shares declined 6.2% to $6.00 in pre-market trading after gaining over 6% on Wednesday.
    • Grifols, S.A. (NASDAQ:GRFS) shares fell 5% to $6.62 in pre-market trading.
    • Fastenal Company (NASDAQ:FAST) shares declined 5.1% to $70.90 in pre-market trading following worse-than-expected first-quarter financial results.
    • Mercury General Corporation (NYSE:MCY) fell 4.5% to $49.00 in pre-market trading. Mercury General is expected to report first-quarter earnings after the markets close on Tuesday, April 30, 2024.

     

    Now Read This: Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20

    Don’t forget to check out our premarket coverage here

    Get the next $FAST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FAST
    $GRFS
    $KMX
    $LOVE

    CompanyDatePrice TargetRatingAnalyst
    Avita Medical Inc.
    $RCEL
    3/5/2026$10.00Outperform
    Northland Capital
    Nanobiotix S.A.
    $NBTX
    2/6/2026Buy
    TD Cowen
    Fastenal Company
    $FAST
    12/15/2025$52.00Hold → Buy
    Jefferies
    Avita Medical Inc.
    $RCEL
    11/20/2025Sell → Neutral
    BTIG Research
    Fastenal Company
    $FAST
    11/13/2025Underperform → Peer Perform
    Wolfe Research
    Fastenal Company
    $FAST
    11/12/2025$38.00Underperform
    Bernstein
    CarMax Inc
    $KMX
    11/12/2025$28.00Underweight
    Barclays
    CarMax Inc
    $KMX
    11/10/2025$35.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $FAST
    $GRFS
    $KMX
    $LOVE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Average Smart Home Faces 30 Cyberattacks a Day - Mercury Insurance Shares How to Stay Protected

    With connected homes under constant digital threat, simple safeguard can reduce both cyber intrusions and real-world lossesLOS ANGELES, April 2, 2026 /PRNewswire/ -- Connected homes are becoming the norm, with millions of Americans relying on Wi-Fi networks, mobile apps and smart devices to manage everything from door locks to thermostats. Mercury Insurance (NYSE/NYSE Texas: MCY) is reminding homeowners that as convenience increases, so does exposure — and that basic cybersecurity practices can help reduce both digital and physical risks."Smart-home technology is incredibly useful, but it also expands the number of entry points into your home — not just digitally, but physically," said Dusti

    4/2/26 12:00:00 PM ET
    $MCY
    Property-Casualty Insurers
    Finance

    CARMAX CELEBRATES 22nd CONSECUTIVE YEAR AS ONE OF FORTUNE MAGAZINE'S 100 BEST COMPANIES TO WORK FOR®

    RICHMOND, Virginia, April 01, 2026 (GLOBE NEWSWIRE) -- Fortune Media and Great Place to Work® have recognized CarMax (NYSE:KMX) as one of the 100 Best Companies to Work For® in 2026. This marks the 22nd consecutive year that CarMax has been named to this prestigious list, which annually recognizes the best companies to work for in the country. CarMax, the nation's largest retailer of used cars, ranks #56 for 2026. "Congratulations to CarMax associates for this recognition, which reflects the culture you've built and strengthened over time," said Craig Cronheim, CarMax's Chief Human Resources Officer. "I'm grateful for the trust, care, and support you show one another, our customers, a

    4/1/26 9:30:00 AM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results

    Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck cancer and lung cancerClinical results reported across multiple tumor types including esophageal cancer, pancreatic cancer, melanoma, head and neck cancer, and lung cancer that supported the broad potential of JNJ-1900 (NBTXR3) across solid tumors treated with radiotherapy next to the completion of the transfer of sponsorship for NANORAY-312Strengthened financial position through the closing of a non-dilutive royalty financing with HealthCare Royalty for up to $71 million and an amendment to the gl

    3/31/26 4:15:00 PM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FAST
    $GRFS
    $KMX
    $LOVE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tuite Tyler

    4 - CARMAX INC (0001170010) (Issuer)

    3/24/26 6:20:08 PM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form 4 filed by Fox Mary

    4 - Lovesac Co (0001701758) (Issuer)

    3/20/26 7:40:33 PM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 4 filed by Nelson Shawn David

    4 - Lovesac Co (0001701758) (Issuer)

    3/20/26 7:39:21 PM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary

    $FAST
    $GRFS
    $KMX
    $LOVE
    SEC Filings

    View All

    SEC Form 10-K filed by The Lovesac Company

    10-K - Lovesac Co (0001701758) (Filer)

    4/2/26 7:35:35 AM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary

    SEC Form S-3 filed by Avita Medical Inc.

    S-3 - AVITA Medical, Inc. (0001762303) (Filer)

    3/31/26 4:54:20 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    SEC Form 6-K filed by Nanobiotix S.A.

    6-K - Nanobiotix S.A. (0001760854) (Filer)

    3/31/26 4:41:24 PM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FAST
    $GRFS
    $KMX
    $LOVE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO O'Toole David D bought $12,450 worth of shares (3,000 units at $4.15), increasing direct ownership by 2% to 140,127 units (SEC Form 4)

    4 - AVITA Medical, Inc. (0001762303) (Issuer)

    2/23/26 4:30:08 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    Amendment: Senior EVP-Sales Miller Charles S. bought $3,101 worth of shares (40 units at $77.53) (SEC Form 4)

    4/A - FASTENAL CO (0000815556) (Issuer)

    2/10/26 4:17:30 PM ET
    $FAST
    RETAIL: Building Materials
    Consumer Discretionary

    Senior EVP-Sales Miller Charles S. bought $1,566 worth of shares (40 units at $39.15) (SEC Form 4)

    4 - FASTENAL CO (0000815556) (Issuer)

    1/27/26 2:33:12 PM ET
    $FAST
    RETAIL: Building Materials
    Consumer Discretionary

    $FAST
    $GRFS
    $KMX
    $LOVE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Avita Medical with a new price target

    Northland Capital initiated coverage of Avita Medical with a rating of Outperform and set a new price target of $10.00

    3/5/26 8:30:26 AM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    TD Cowen initiated coverage on Nanobiotix

    TD Cowen initiated coverage of Nanobiotix with a rating of Buy

    2/6/26 8:11:18 AM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Fastenal upgraded by Jefferies with a new price target

    Jefferies upgraded Fastenal from Hold to Buy and set a new price target of $52.00

    12/15/25 9:05:06 AM ET
    $FAST
    RETAIL: Building Materials
    Consumer Discretionary

    $FAST
    $GRFS
    $KMX
    $LOVE
    Leadership Updates

    Live Leadership Updates

    View All

    Starboard Delivers Letter to CarMax

    Views Appointment of New CEO Keith Barr as Timely Opportunity to Address Fixable Execution Gaps and Unlock CarMax's Full Value Potential Has Nominated Directors to Help Support the Next Phase of Execution and Accelerate Shareholder Value Creation Believes CarMax's Structurally Superior Omnichannel Model Is Not Reflected in Current Performance Sees Clear Opportunities to Drive Improvement Through Enhanced Digital Execution, Reconditioning Efficiencies and Dynamic Pricing Urges a Substantially Expanded SG&A Reduction Program to Restore Cost Discipline and Enhance Long-Term Earnings Power Starboard Value LP (together with its affiliates, "Starboard"), a significant stockholder of Car

    3/11/26 8:00:00 AM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    CarMax Names Keith Barr as Chief Executive Officer

    CarMax, Inc. (NYSE:KMX) ("CarMax" or the "Company") today announced that Keith Barr has been appointed President and Chief Executive Officer, and a member of the Board of Directors ("the Board"), effective March 16, 2026. David McCreight, current Interim President and CEO of CarMax, will transition to his prior duties as an independent Director of the Board. Tom Folliard will remain in his role as Interim Executive Chair of the Board until the Company's Annual Meeting in June 2026, after which he is expected to resume his prior duties as non-executive Chair of the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026021283385

    2/12/26 6:50:00 AM ET
    $IHG
    $KMX
    Hotels/Resorts
    Consumer Discretionary
    Retail-Auto Dealers and Gas Stations

    AVITA Medical Announces Changes to its Board of Directors

    Veteran healthcare executive Joe Woody joins the BoardLou Panaccio retires after over a decade of service VALENCIA, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced the appointment of Joe Woody as a new non-executive Director and the retirement of Lou Panaccio, who served as Chairman from July 2014 to August 2025. "We are pleased to welcome Joe to the Board. His extensive track record leading global med-tech companies and driving commercial excellence will be invaluable as we continue to scale AVITA Medical's growth," said Cary Vance, Interim CEO of

    1/5/26 4:05:00 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    $FAST
    $GRFS
    $KMX
    $LOVE
    Financials

    Live finance-specific insights

    View All

    NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results

    Global development program for JNJ-1900 (NBTXR3) proceeded as planned, building toward opportunity to address one of the largest untapped markets in oncology through lead programs in head and neck cancer and lung cancerClinical results reported across multiple tumor types including esophageal cancer, pancreatic cancer, melanoma, head and neck cancer, and lung cancer that supported the broad potential of JNJ-1900 (NBTXR3) across solid tumors treated with radiotherapy next to the completion of the transfer of sponsorship for NANORAY-312Strengthened financial position through the closing of a non-dilutive royalty financing with HealthCare Royalty for up to $71 million and an amendment to the gl

    3/31/26 4:15:00 PM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Fastenal Company Announces Conference Call to Review 2026 First Quarter Earnings

    Fastenal Company (NASDAQ:FAST) ('Fastenal,' 'we,' 'our,' or 'us') announced the date and time for its conference call to review 2026 first quarter results, as well as current operations. The conference call will be broadcast live over the Internet on Monday, April 13, 2026, at 9:00 a.m. central time. To access the call, please visit the following Web address: https://investor.fastenal.com/events.cfm Our conference call presentation (which includes information, supplemental to that contained in our earnings announcement, regarding results for the quarter) will be available at 6:00 a.m., central time, on the day of the conference call. To access the presentation, please visit the follow

    3/27/26 4:05:00 PM ET
    $FAST
    RETAIL: Building Materials
    Consumer Discretionary

    NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

    PARIS and CAMBRIDGE, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ:NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 31st, 2026, after the close of the U.S. market. This release will be followed by a conference call and webcast on Wednesday, April 1st, 2026, at 8:00 AM EDT / 2:00 PM CEST, prior to the open of the U.S. market. During the call, Laurent Levy, chief executive office

    3/26/26 4:15:00 PM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $FAST
    $GRFS
    $KMX
    $LOVE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Lovesac Company

    SC 13G/A - Lovesac Co (0001701758) (Subject)

    11/14/24 4:34:24 PM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Grifols S.A.

    SC 13G/A - Grifols SA (0001438569) (Subject)

    11/14/24 11:46:03 AM ET
    $GRFS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by The Lovesac Company

    SC 13G - Lovesac Co (0001701758) (Subject)

    11/14/24 8:00:04 AM ET
    $LOVE
    Other Specialty Stores
    Consumer Discretionary